CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity

by Barbara Dillinger, Sarah Ahmadi-Erber, Klara Soukup, Angela Halfmann, Silke Schrom, Bernard Vanhove, Bernard Vanhove, Bernard Vanhove, Peter Steinberger, Rene Geyeregger, Rene Geyeregger, Stephan Ladisch, Alexander Michael Dohnal
Published 2017-09-01